Novo Nordisk reports liver improvements with Wegovy in some patients
coldsnowstorm/iStock via Getty Images
Novo Nordisk (NVO) said Sunday that its weight-loss drug Wegovy was associated with improvements in several measures of liver health among patients with a serious liver disease who had a body mass index below 27.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.